Neural mechanisms and axon reflexes in asthma: Where are we?

Biochemical Pharmacology

Volumn 51, Issue 10, 1996, Pages 1247-1257

  Verleden, Geert M ^a,b  

^a Unit of Respiratory Pharmacology   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Axon reflex; Guinea pig airways; Human airways; Modulation; NANC; Neuropeptides; Tachykinins

Indexed keywords

2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; ANTIASTHMATIC AGENT; ANTIHISTAMINIC AGENT; ATROPINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRADYKININ; BUMETANIDE; CAPSAICIN; CROMOGLYCATE DISODIUM; EPINASTINE; FK 224; FUROSEMIDE; KETOTIFEN; N BENZYL N2 [4 HYDROXY 1 [(1 METHYL 1H INDOL 3 YL)CARBONYL]PROLYL] N METHYL 3 (2 NAPHTHYL)ALANINAMIDE; NEDOCROMIL SODIUM; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 2 RECEPTOR ANTAGONIST; NEUROKININ A; NEUROPEPTIDE; SUBSTANCE P; SUBSTANCE P ANTAGONIST; THIORPHAN;

ADRENERGIC NERVE; AIRWAY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CHOLINERGIC NERVE; HUMAN; INFLAMMATORY DISEASE; INNERVATION; NERVE FIBER; NERVE FIBER C; NONADRENERGIC NONCHOLINERGIC NERVE; NONHUMAN; PRIORITY JOURNAL; REFLEX; SYMPTOMATOLOGY;

ANIMALS; ASTHMA; AXONS; CATECHOLAMINES; GUINEA PIGS; HUMANS; NEURONS; REFLEX;

EID: 0029985896     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(95)02253-8     Document Type: Note

References (176)

1. Nadel JA, Inflammation and asthma. J Allergy Clin lmmunol 73: 651-656, 1984.
2. Djukanovic R, Roche WR, Wilson JW, Beasley CR, Twentymann OP, Howarth PH and Holgate ST, Mucosal inflammation in asthma. Am Rev Respir Dis 142: 434-457, 1990.
3. Kay AB, Asthma and inflammation. J Allergy Clin Immunol 87: 893-910, 1991.
4. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV and Kay AB, Eosinophils and mast cells in bronchoalveolar lavage in mild asthma: Relationship to bronchial hyperreactivity. Am Rev Respir Dis 137: 62-69, 1988.
5. Beasley R, Roche WR, Roberts JA and Holgate ST, Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 139: 806-817, 1989.
6. Bradley BL, Azzawi M, Jacobson M, Asoufi B, Collins JV, Irani AA, Schwartz LB, Durham SR, Jeffery PK and Kay AB, Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: Comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness. J Allergy Clin Immunol 88: 661-674, 1991.
7. Bousquet J, Chanez P, Lacoste JY, Barnéon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P and Michel F-B, Eosinophilic inflammation in asthma. N Engl J Med 323: 1033-1039, 1990.
8. Dunnil MS, Massarella GR and Anderson JA, A comparison of the quantitative anatomy of the bronchi in normal subjects, in status asthmaticus, in chronic bronchitis, and in emphysema. Thorax 24: 176-179, 1969.
9. Roche WR, Beasley R, Williams JH and Holgate ST, Subepithelial fibrosis in the bronchi of asthmatics. Lancet 2: 520-523, 1989.
10. Stewart AG, Tomlinson PR and Wilson J, Airway wall remodeling in asthma: A novel target for the development of anti-asthma drugs. Trends Pharmacol Sci 14: 275-279, 1993.
11. Laitinen LA, Heino M, Kava T and Haahtela T, Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am Rev Respir Dis 131: 599-606, 1985.
12. Hogg JC, James AL and Pare PD, Evidence for inflammation in asthma. Am Rev Respir Dis 143: S39-S42, 1991.
13. Laitinen A and Laitinen LA, Airway morphology: Epithelium/basement membrane. Am J Respir Crit Care Med 150: S14-S17, 1994.
14. Laitinen LA and Laitinen A, Is asthma also a vascular disease? Am Rev Respir Dis 135: A474, 1987.
15. Ohashi Y, Motojima S, Fukuda T and Makino S, Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. Am Rev Respir Dis 145: 1469-1476, 1992.
16. Gleich GJ and Loegering DA, Immunobiology of eosinophils. Annu Rev Immunol 129: 429-459, 1984.
17. Frigas E, Loegering DA, Soley GL, Farrow GM and Gleich GJ, Elevated levels of eosinophil granule major basic protein in the sputum of patients with bronchial asthma. Mayo Clin Proc 56: 345-353, 1981.
18. Filley WV, Holley KE, Kephart GM and Gleich GJ, Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet 2: 11-16, 1982.
19. Lee TH and Sousa AR, Immunoinflammatory role of the airway epithelial cell in asthma. Eur Respir Rev 4: 368-370, 1994.
20. Laitinen A, Ultrastructural organisation of intraepithelial nerves in the human airway tract. Thorax 40: 488-492, 1985.
21. Barnes PJ, Asthma as an axon reflex. Lancet 1: 242-245, 1986.
22. Barnes PJ, Belvisi MG and Rogers D, Modulation of neurogenic inflammation: Novel approaches to inflammatory disease. Trends Pharmacol Sci 11: 185-189, 1990.
23. Grundström N, Andersson RGG and Wikberg JES, Pharmacological characterization of the autonomous innervation of the guinea pig tracheobronchial smooth muscle. Acta Pharmacol Toxicol 49: 150-157, 1981.
24. Richardson JB, Nerve supply to the lungs. Am Rev Respir Dis 119: 785-802, 1979.
25. Undem BJ, Myers AC, Barthlow H and Weinreich D, Vagal innervation of guinea pig bronchial smooth muscle. J Appl Physiol 69: 1336-1346, 1990.
26. Richardson JB and Ferguson CC, Neuromuscular structure and function in the airways. Fedn Proc 38: 202-208, 1979.
27. Laitinen A, Autonomic innervation of the human respiratory tract as revealed by histochemical and ultrastructural methods. Eur J Respir Dis 66: 1-42, 1985.
28. Laitinen LA and Laitinen A, Innervation of airway smooth muscle. Am Rev Respir Dis 136: S38-S42, 1987.
29. Partanen M, Laitinen A, Herronen A, Toivanen M and Laitinen LA, Catecholamine- and acetylcholinesterase-containing nerves in the human lower respiratory tract. Histochemistry 76: 175-188, 1982.
30. Nadel JA, Gabezas GA and Austin JHM, In vivo roentgenographic examination of parasympathetic innervation of small airways: Use of powdered tantalum and a fine focal spot X-ray tube. Invest Radiol 6: 9-17, 1971.
31. Richardson JB and Beland J, Nonadrenergic inhibitory nervous system in human airways. J Appl Physiol 41: 764-771, 1976.
32. Barnes PJ, Basbaum CB and Nadel JA, Autoradiographic localization of autonomic receptors in airway smooth muscle: Marked differences between large and small airways. Am Rev Respir Dis 127: 758-762, 1983.
33. Barnes PJ, Airway epithelial receptors. Eur Respir Rev 4: 371-379, 1994.
34. Barnes PJ, Muscarinic receptor subtypes in human airways. Life Sci 52: 521-528, 1993.
35. Bloom JW, Yamamura HI, Baumgartner C and Halonen M, A muscarinic receptor with high affinity for pirenzepine mediates vagally induced bronchoconstriction. Eur J Pharmacol 133: 21-27, 1987.
36. 1) muscarinic receptors in vagally mediated bronchoconstriction in humans. Am Rev Respir Dis 139: 446-449, 1989.
37. Barnes PJ, Modulation of neurotransmission in airways. Physiol Rev 72: 699-729, 1992.
38. Minette PAH and Barnes PJ, Prejunctional inhibitory muscarinic receptors on cholinergic nerves in human and guinea pig airways. J Appl Physiol 64: 2532-2537, 1988.
39. Minette PAH, Lammers JW, Dixon CMS, McCusker MT and Barnes PJ, A muscarinic antagonist inhibits vagal reflex bronchoconstriction in normal but not in asthmatic subjects. J Appl Physiol 67: 2461-2465, 1988.
40. Ayala LE and Ahmed T, Is there a loss of protective muscarinic receptor mechanisms in asthma? Chest 96: 1285-1291, 1991.
41. Mak JCW and Barnes PJ, Autoradiographic visualization of muscarinic receptor subtypes in human and guinea pig lung. Am Rev Respir Dis 141: 1559-1568, 1990.
42. Mak JCW, Baraniuk JN and Barnes PJ, Localization of muscarinic receptor subtype mRNAs in human lung. Am J Respir Cell Mol Biol 7: 344-348, 1992.
43. Sant'Ambrogio G, Information arising from the tracheobronchial tree of mammals. Physiol Rev 62: 531-569, 1982.
44. Guz A and Trenchard DW, Pulmonary stretch receptor activity in man: A comparison with dog and cat. J Physiol (Lond) 213: 329-343, 1971.
45. Barnes PJ, Neural control of human airways in health and disease. Am Rev Respir Dis 134: 1289-1314, 1986.
46. Widdicombe JG, Receptors in the trachea and the bronchi of the cat. J Physiol (Lond) 123: 71-104, 1954.
47. Leff AR, Endogenous regulation of bronchomotor tone. Am Rev Respir Dis 137: 1198-1216, 1988.
48. Fennerty AG, Banks J, Bevan C and Smith AP, Role of airway receptors in the breathing pattern of patients with chronic obstructive lung disease. Thorax 40: 268-271, 1985.
49. Coleridge JCG and Coleridge HM, Afferent vagal C-fiber innervation of the lung and airways and its functional significance. Rev Physiol Biochem Pharmacol 99: 1-110, 1984.
50. Foreman JC and Jordan C, Neurogenic inflammation. Trends Pharmacol Sci 5: 116-119, 1984.
51. Szolcsányi J, Antidromic vasodilatation and neurogenic inflammation. Agents Actions 23: 4-11, 1988.
52. Nadel JA, Autonomic regulation of airway smooth muscle. In Physiology and Pharmacology of the Airways (Ed. Lenfant C), Vol. 15, pp. 217-239. Marcel Dekker, New York, 1980.
53. Russell JA, Nonadrenergic inhibitory innervation of canine airways. J Appl Physiol 48: 16-22, 1980.
54. Altiere R and Diamond L, Relaxation of cat tracheobronchial and pulmonary arterial smooth muscle by vasoactive intestinal peptide: Lack of influence of peptidase inhibitors. Br J Pharmacol 82: 338-342, 1984.
55. de Jongste JC, Jongejan RC and Kerrebijn KF, Control of airway caliber by autonomie nerves in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 143: 1421-1426, 1991.
56. Davis C, Kannan MS, Jones TR and Daniel EE, Control of human airway smooth muscle: In vitro studies. J Appl Physiol 53: 1080-1087, 1982.
57. Brown MJ, Jenner DA, Allison DJ and Dollery DT, Variations in individual organ release of noradrenaline measured by an improved radioenzymatic technique; Limitations of peripheral venous measurements in the assessment of sympathetic nervous activity. Clin Sci 61: 585-590, 1981.
58. Berkin KG, Inglis GC, Ball SG and Thomson NC, Airway response to low concentrations of adrenaline and noradrenaline in normal subjects. Q J Exp Physiol 70: 203-209, 1985.
59. Warren JB, Dalton N, Turner C and Clark TJH, Protective effect of circulating epinephrine within the physiologic range on the airway response to inhaled histamine in nonasthmatic subjects. J Allergy Clin Immunol 74: 683-686, 1984.
60. Barnes PJ, The third nervous system in the lung: Physiology and clinical perspectives. Thorax 39: 561-567, 1984.
61. Linden A, Löfdahl C-G, Ullman A and Skoogh BE, Nonadrenergic, noncholinergic responses stabilize smooth muscle tone, with and without parasympathetic activation, in guinea pig isolated airways. Eur Respir J 6: 425-433, 1993.
62. Linden A and Skoogh BE, NANC responses - Role in control of airway tone. Respir Med 88: 249-265, 1994.
63. Polak JM and Bloom SR, Peptidergic nerves of the gastrointestinal tract. Invest Cell Pathol 1: 301-326, 1978.
64. Polak JM and Bloom SR, Regulatory peptides in the respiratory tract of man and other animals. Exp Lung Res 3: 313-328, 1982.
65. Coburn RJ and Tomita T, Evidence for nonadrenergic inhibitory nerves in the guinea pig trachealis muscle. Am J Physiol 224: 1072-1080, 1973.
66. MacKay TW, Fitzpatrick MF and Douglas NJ, Nonadrenergic, noncholinergic nervous system and overnight airway calibre in asthmatic and normal subjects. Lancet 338: 1289-1292, 1991.
67. Szarek JL, Gillespie MN, Altiere RJ and Diamond L, Reflex activation of the nonadrenergic, noncholinergic inhibitory nervous system in feline airways. Am Rev Respir Dis 133: 1159-1162, 1986.
68. Michoud MC, Amyot R, Jenneret-Grosjean A and Couture J, Reflex decrease of histamine-induced bronchoconstriction after laryngeal stimulation in humans. Am Rev Respir Dis 137: 618-622, 1987.
69. Ichinose M, Inoue H, Miura M, Yafuso N, Nogasmi H and Takishima T, Possible sensory receptors of nonadrenergic inhibitory system. J Appl Physiol 63: 923-929, 1987.
70. Ichinose M, Inoue H, Miura M and Takishima T, Nonadrenergic bronchodilation in normal subjects. Am Rev Respir Dis 138: 31-34, 1988.
71. Inoue H, Ichinose M, Miura M, Iijima H, Kimura K, Katsumata U, Hataoka I, Okada S, Asano M and Takishima T, Nonadrenergic inhibitory nervous systems in the airways. Am Rev Respir Dis 143: S15-S17, 1991.
72. 4-macromolecule secretion from tracheal glands of ferrets. J Appl Physiol 57: 457-466, 1984.
73. Burnstock G, Purinergic nerves. Pharmacol Rev 24: 509-581, 1972.
74. Dey RD, Shannon WA Jr and Said SI, Localization of VIP-immunoreactive nerves in airways and pulmonary vessels of dogs, cats and human subjects. Cell Tissue Res 220: 231-238, 1981.
75. Morice A, Unwin RJ and Sever PS, Vasoactive intestinal peptide causes bronchodilatation and protects against histamine-induced bronchoconstriction in asthmatic subjects. Lancet II: 1125-1226, 1983.
76. Barnes PJ and Dixon CMS, The effect of inhaled vasoactive intestinal peptide on bronchial reactivity to histamine in humans. Am Rev Respir Dis 130: 162-166, 1984.
77. Canning BJ and Undem BJ, Relaxant innervation of the guinea-pig trachealis: Demonstration of capsaicin-sensitive and -insensitive vagal pathways. J Physiol (Lond) 460: 719-739, 1993.
78. Pype JL, Verleden GM and Demedts MG, Opioids modulate the cholinergic contraction but not the iNANC relaxation in guinea pig airways in vitro. Eur Respir J 7(Suppl 18): 284s, 1994.
79. Stretton CD, Belvisi MG and Barnes PJ, Modulation of neural bronchoconstrictor responses in the guinea pig respiratory tract by vasoactive intestinal peptide. Neuropeptides 18: 149-157, 1991.
80. Belvisi MG, Miura M, Stretton CD and Barnes PJ, Endogenous vasoactive intestinal peptide and nitric oxide modulate cholinergic neurotransmission in guinea pig trachea. Eur J Pharmacol 213: 97-102, 1993.
81. Fisher JT, Andersson JW and Waldron MA, Nonadrenergic, noncholinergic neurotransmitter of feline trachealis: VIP or nitric oxide? J Appl Physiol 74: 31-39, 1993.
82. Belvisi MG, Stretton CD, Verleden GM, Tadjkarimi S, Yacoub MH and Barnes PJ, Inhibitory NANC nerves in human tracheal smooth muscle: A quest for the neurotransmitter. J Appl Physiol 73: 2505-2510, 1992.
83. G-nitro-L-arginine of nonadrenergic- noncholinergic-mediated relaxations of human isolated central and peripheral airways. Am Rev Respir Dis 146: 1543-1547, 1992.
84. Bai TR and Bramley AM, Effect of an inhibitor of nitric oxide synthase on neural relaxation of human bronchi. Am J Physiol 264: L425-L430, 1993.
85. 6-monomethyl L-arginine on the responses of the rat anococcygeus muscle to NANC nerve stimulation. Br J Pharmacol 98: 1080-1082, 1989.
86. Bult H, Boeckxstaens GE, Pelckmans PA, Jordaens FH, Van Maercke YM and Herman AG, Nitric oxide as an inhibitory nonadrenergic, noncholinergic neurotransmitter. Nature 345: 346-347, 1990.
87. Li CG and Rand MJ, Evidence that part of the NANC relaxant response of guinea-pig trachea to electrical field stimulation is mediated by nitric oxide. Br J Pharmacol 102: 91-94, 1991.
88. Bredt DS, Hwang PM and Snyder SH, Localisation of nitric oxide synthase indicating a neural role for nitric oxide. Nature 357: 768-770, 1990.
89. Ward JR, Fox AJ, Miura M, Tadjkarimi S, Yacoub MH, Barnes PJ and Belvisi MG, Modulation of cholinergic neurotransmission by nitric oxide in human airway smooth muscle. J Clin Invest 92: 736-742, 1993.
90. Barnes PJ, Nitric oxide and airways. Eur Respir J 6:163-165, 1993.
91. Ellis JL and Undem BJ, Nonadrenergic, noncholinergic contraction in the electrically field stimulated guinea pig trachea. Br J Pharmacol 101: 875-880, 1990.
92. 1-like receptor. J Appl Physiol 77: 1135-1141, 1994.
93. Martling CR, Saria A, Andersson P and Lundberg JM, Capsaicin pretreatment inhibits vagal cholinergic and noncholinergic control of pulmonary mechanics in the guinea-pig. Naunyn Schmiedebergs Arch Pharmacol 325: 343-348, 1984.
94. Lundberg JM, Saria A, Brodin E, Rosell S and Folkers K, A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea pig. Proc Natl Acad Sci USA 80: 1120-1124, 1983.
95. Lou YP, Lee LY, Satoh H and Lundberg JM, Postjunctional inhibitory effect of the NK-2 receptor antagonist SR 48968, on sensory NANC bronchoconstriction in the guinea pig. Br J Pharmacol 109: 765-773, 1993.
96. Lundberg JM, Hokfelt T, Martling C-R, Saria A and Cuelo C, Substance P-immunoreactive sensory nerves in the lower respiratory tract of various mammals including man. Cell Tissue Res 235: 251-261, 1984.
97. Ollerenshaw SL, Jarvis D, Sullivan CE and Woolcock AJ, Substance P immunoreactive nerves in airways from asthmatics and nonasthmatics. Eur Respir J 4: 673-682, 1991.
98. Stretton CD, Belvisi MG and Barnes PJ, Sensory nerve depletion potentiates inhibitory nonadrenergic, noncholinergic nerves in guinea pig airways. Eur J Pharmacol 184: 333-337, 1990.
99. Stretton CD, Belvisi MG and Barnes PJ, The effect of sensory nerve depletion on cholinergic neurotransmission in guinea pig airways. J Pharmacol Exp Ther 260: 1073-1080, 1992.
100. Barnes PJ, Baraniuk JN and Belvisi MG, Neuropeptides in the respiratory tract. Part 1. Am Rev Respir Dis 144: 1187-1198, 1991.
101. Martling CR, Theodorsson-Norheim E and Lundberg JM, Occurrence and effects of multiple tachykinins: Substance P, neurokinin A and neurokinin K in human lower airways. Life Sci 40: 1633-1643, 1987.
102. Guard S and Watson S, Tachykinin receptor subtypes: Classification and membrane signalling mechanisms. Neurochem Int 18: 149, 1991.
103. 125I]NKA binding due to NK-2 receptor antagonism. Acta Physiol Scand 144: 221-231, 1992.
104. Watling KJ, Nonpeptide antagonists herald new era in tachykinin research. Trends Pharmacol Sci 13: 266-269, 1992.
105. Delay-Goyet P and Lundberg JM, Cigarette smoke-induced airway oedema is blocked by the NK-1 antagonist, CP 96345. Eur J Pharmacol 203: 157-158, 1991.
106. Lembeck FJ, Donnerer J, Tsuchiya M and Nagahisa A, The non peptide tachykinin antagonist CP-96,345 is a potent inhibitor of neurogenic inflammation. Br J Pharmacol 105: 527-530, 1992.
107. 2 receptor selectivity. J Pharmacol Exp Ther 262: 398-402, 1992.
108. Hirayama Y, Lei Y-H, Barnes PJ and Rogers DF, Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo. Br J Pharmacol 108: 844-851, 1993.
109. 1 receptor antagonist, FK888. Br J Pharmacol 107: 785-798, 1992.
110. Lundberg JM, Martling CR and Saria A, Substance P and capsaicin-induced contraction of human bronchi. Acta Physiol Scand 119: 49-53, 1983.
111. Fuller RW, Dixon CMS and Barnes PJ, The bronchoconstrictor response to inhaled capsaicin in humans. J Appl Physiol 85: 1080-1084, 1985.
112. Midgren B, Hansson L, Karlsson J-A, Simonsson BG and Persson CGA, Capsaicin-induced cough in humans. Am Rev Respir Dis 146: 347-351, 1992.
113. Advenier C, Naline E, Drapeau G and Regloi D, Relative potencies of neurokinins in guinea pig and human bronchus. Eur J Pharmacol 139: 133-137, 1987.
114. Ellis JL, Undem BJ, Kays JS, Ghanekar SV and Buckner CK, Pharmacological examination of receptors mediating contractile responses to tachykinins in airways isolated from human, guinea pig and hamster. J Pharmacol Exp Ther 267: 95-101, 1993.
115. Joos GF, Germonpre PR, Kips JC, Peleman RA and Pauwels RA, Sensory neuropeptides and the human lower airways: Present state and future directions. Eur Respir J 7: 1161-1171, 1994.
116. Crimi N, Palermo F and Oliveri R, Effect of nedocromil on bronchospasm induced by inhalation of substance P in asthmatic subjects. Clin Allergy 18: 375-382, 1988.
117. Evans TW, Dixon CM, Clarke B, Conradson TB and Barnes PJ, Comparison of neurokinin A and substance P on cardiovascular and airway function in man. Br J Clin Pharmacol 25: 273-275, 1988.
118. Joos G, Pauwels R and van der Straeten ME, Effect of inhaled substance P and neurokinin A in the airways of normal and asthmatic subjects. Thorax 42: 779-783, 1987.
119. Cheung D, Timmers MC, Zwinderman AH, den Hartigh J, Dijkman JH and Sterk PJ, Neutral endopeptidase activity and airway hyperresponsiveness to neurokinin A in asthmatic subjects in vivo. Am Rev Respir Dis 148: 1467-1473, 1993.
120. Crimi N, Palermo F, Oliveri R, Polosa R, Magri S and Mistretta A, Inhibition of neutral endopeptidase potentiates bronchoconstriction induced by neurokinin A in asthmatic patients. Clin Exp Allergy 24: 115-120, 1994.
121. Cheung D, Bel EH, Den Hartigh J, Dijkman JH and Sterk PJ, The effect of an inhaled neutral endopeptidase inhibitor, thiorphan, on airway responses to neurokinin A in normal humans in vivo. Am Rev Respir Dis 145: 1275-1280, 1992.
122. Joos GF, Pauwels RA and van der Straeten ME, The effect of nedocromil sodium on the bronchoconstrictor effect of neurokinin A in subjects with asthma. J Allergy Clin Immunol 83: 663-668, 1989.
123. Joos GF, Pauwels RA and van der Straeten ME, The mechanism of tachykinin-induced bronchoconstriction in the rat. Am Rev Respir Dis 137: 1038-1044, 1988.
124. Joos GF and Pauwels RA, The in vivo effect of tachykinins on airway mast cells of the rat. Am Rev Respir Dis 148: 922-926, 1993.
125. Verleden GM, Belvisi MG, Stretton CD and Barnes PJ, Nedocromil sodium modulates nonadrenergic, noncholinergic bronchoconstrictor nerves in guinea pig airways in vitro. Am Rev Respir Dis 143: 114-118, 1991.
126. Reinsprecht M, Pecht I, Schindler H and Romanin C, Potent block of Cl-channels by antiallergic drugs. Biochem Biophys Res Commun 188: 957-963, 1992.
127. Crossman DC, Dashwood MR, Taylor GW, Wellings R and Fuller RW, Sodium cromoglycate: Evidence of tachykinin antagonist activity in the human skin. J Appl Physiol 75: 167-172, 1993.
128. Subramanian N, Ruesch C and Bertrand C, Cromoglycate does not have tachykinin-antagonistic activity at human NK-1 and NK-2 receptors. Am J Respir Crit Care Med 151: A823, 1995.
129. Rogers DF, Aursudkij B and Barnes PJ, Effects of tachykinins on mucus secretion on human bronchus in vitro. Eur J Pharmacol 174: 283-286, 1989.
130. Luts A, Uddman R, Alm P, Basterna J and Sundler F, Peptide containing nerve fibers in human airways: Distribution and coexistence pattern. Int Arch Allergy Immunol 101: 52-60, 1993.
131. Tomaki M, Ichinose M, Miura M, Hirayama Y, Yamauchi H, Nakajima N and Shirato K, Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am J Respir Crit Care Med 151: 613-617, 1995.
132. Nieber K, Baumgarten CR, Rathsack R, Furkert J, Oehme P and Kunkel G, Substance P and β-endorphine-like immunoreactivity in lavage fluid of subjects with and without allergic asthma. J Allergy Clin Immunol 90: 646-652, 1992.
133. Nadel JA, Neutral endopeptidase modulates neurogenic inflammation. Eur Respir J 4: 745-754, 1991.
134. Sterk PJ, Virus-induced airway hyperresponsiveness in man. Eur Respir J 6: 894-902, 1993.
135. Elwood W, Lötvall JO, Barnes PJ and Chung KF, Airway hyperresponsiveness to acetylcholine and to tachykinins after respiratory virus infection in the guinea pig. Ann Allergy 70: 231-236, 1993.
136. Inoue H, Koto H, Takata S, Aizawa H and Ikeda T, Excitatory role of axon reflex in bradykinin-induced contraction of guinea pig tracheal smooth muscle. Am Rev Respir Dis 146: 1548-1552, 1992.
137. Ichinose M, Belvisi MG and Barnes PJ, Bradykinin-induced bronchoconstriction in guinea pig in vivo: Role of neural mechanisms. J Pharmacol Exp Ther 253: 594-599, 1990.
138. 2 and thromboxane prostanoid receptors. Am J Respir Crit Care Med 150: 1012-1018, 1994.
139. Nakajima N, Ichinose M, Takahashi T, Yamauchi H, Igarashi A, Miura M, Inoue H, Takishima T and Shirato K, Bradykinin-induced airway inflammation. Contribution of sensory neuropeptides differs according to airway site. Am J Respir Crit Care Med 149: 694-698, 1994.
140. Fuller RW, Dixon CMS, Cuss FMC and Barnes PJ, Bradykinin-induced bronchoconstriction in man: Mode of action. Am Rev Respir Dis 135: 176-180, 1987.
141. Dixon CMS and Barnes PJ, Bradykinin-induced bronchoconstriction: Inhibition by nedocromil sodium and sodium cromoglycate. Br J Clin Pharmacol 270: 8310-8360, 1989.
142. Kaufman MP, Coleridge HM, Coleridge JCG and Baker DG, Bradykinin stimulates afferent vagal C-fibers in intrapulmonary airways of dogs. J Appl Physiol 48: 511-517, 1980.
143. ®) as an anti-inflammatory agent for the treatment of chronic asthma. Clin Exp Allergy 24: 612-623, 1994.
144. Thomson NC, Nedocromil sodium: An overview. Respir Med 83: 269-276, 1989.
145. Karlsson J-A, A role for capsaicin sensitive tachykinin containing nerves in chronic coughing and sneezing but not in asthma. A hypothesis. Thorax 48: 396-400, 1993.
146. Ujiie Y, Sekizawa K, Aikawa T and Sasaki H, Evidence for substance P as an endogenous substance causing cough in guinea pigs. Am Rev Respir Dis 148: 1628-1632, 1993.
147. Ryan WJ, Processing of endogenous polypeptides by the lung. Annu Rev Physiol 44: 241-255, 1980.
148. Hargreaves MR and Benson MK, Inhaled sodium cromoglycate in angiotensin-converting enzyme inhibitor cough. Lancet 345: 13-16, 1995.
149. Ichinose M, Nakajima N, Takahashi T, Yamauchi H, Inoue H and Takishima T, Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist. Lancet 340: 1248-1251, 1992.
150. Joos GF, Van Schoor J, Kips JC and Pauwels RA, The effect of inhaled FK224, an NK-1 and NK-2 receptor antagonist, on neurokinin A-induced bronchoconstriction in asthmatics. Am J Respir Crit Care Med 149: A890, 1994.
151. Elwood WE, Lötvall JO, Barnes PJ and Chung KF, Loop diuretics inhibit cholinergic and noncholinergic nerves in guinea pig airways in vitro. Am Rev Respir Dis 143: 1340-1343, 1991.
152. Verleden GM, Pype JM and Demedts MG, Furosemide and bumetanide, but not nedocromil sodium, modulate nonadrenergic relaxation in guinea pig trachea in vitro. Am J Respir Crit Care Med 149: 138-144, 1994.
153. Verleden GM, Pype JL, Deneffe G and Demedts MG, Effect of loop diuretics on cholinergic neurotransmission in human airways in vitro. Thorax 49: 657-663, 1994.
154. Barnes PJ, Diuretics and asthma. Thorax 48: 195-196, 1993.
155. Mazzarella G, Grella E, Romano L, Perna A, Marzo C, Guarino C, Cammarata A, Bianco A and Liccardo G, Protective effects of nedocromil sodium on cellular and biohumoral components present in the bronchial alveolar lavage fluid and in peripheral blood in atopic asthmatics. Respiration 61: 207-213, 1994.
156. Yates DH, O'Connor BJ, Yilmaz G, Aikman S, Worsdell M, Barnes PJ and Chung KF, Effect of acute and chronic inhaled furosemide on bronchial hyperresponsiveness in mild asthma. Am J Respir Crit Care Med, in press.
157. Miura M, Belvisi MG and Barnes PJ, Modulation of nonadrenergic, noncholinergic neural bronchoconstriction by bradykinin in anesthetized guinea pigs in vivo. J Pharmacol Exp Ther 268: 482-486, 1994.
158. Belvisi MG, Chung KF, Jackson DM and Barnes PJ, Opioid modulation of noncholinergic neural bronchoconstriction in guinea pig in vivo. Br J Pharmacol 95: 413-418, 1988.
159. 2-adrenoceptors and opiate receptors. Eur J Pharmacol 163: 15-23, 1989.
160. 2-adrenoceptors. J Appl Physiol 74: 1195-1199, 1993.
161. Verleden GM, Belvisi MG, Stretton CD and Barnes PJ, Modulation of neurotransmission in guinea pig airways by purinoceptors. Am Rev Respir Dis 143: A357, 1991.
162. B-receptors. Br J Pharmacol 97: 1225-1234, 1989.
163. 3-receptors modulate nonadrenergic, noncholinergic bronchoconstriction in guinea pig in vivo. Eur J Pharmacol 174: 49-55, 1989.
164. Ward JR, Fox AJ, Barnes PJ and Belvisi MG, Inhibition of excitatory nonadrenergic, noncholinergic bronchoconstriction in guinea pig airways in vitro by activation of an atypical 5-HT receptor. Br J Pharmacol 111: 1095-1102, 1994.
165. Ichinose M and Barnes PJ, A potassium channel activator modulates excitatory noncholinergic and cholinergic neurotransmission in guinea pig airways. J Pharmacol Exp Ther 252: 1207-1212, 1990.
166. Stretton CD, Miura M, Belvisi MG and Barnes PJ, Calcium-activated potassium channels mediate prejunctional inhibition of peripheral sensory nerves. Proc Natl Acad Sci USA 89: 1325-1329, 1992.
167. +-channel blockets 4-aminopyridine and charybdotoxin on sensory nerves in guinea pig lung. Pharmacol Toxicol 72: 139-144, 1993.
168. Verleden GM, Pype JL and Demedts MG, Ketotifen modulates noncholinergic contraction in guinea pig airways in vitro by a prejunctional nonhistamine receptor. J Allergy Clin Immunol 94: 207-214, 1994.
169. Dupont LJ, Demedts MG and Verleden GM, Epinastine modulates noncholinergic contraction in guinea pig airways in vitro. Am J Respir Crit Care Med 151: A824, 1995.
170. Rackham A, Brown CA, Chandra RK, Ho P, Hoogerwerf PE, Kennedy RJ, Knight A, Langer H, Milne J, Moote DW, Nickerson GH, Rosen L, Stephenson H, Broadhead M, Lalonde Y and St-Pierre J-P, A Canadian multicenter study with Zaditen (ketotifen) in the treatment of bronchial asthma in children aged 5 to 17 years. J Allergy Clin Immunol 84: 286-296, 1989.
171. Fügner A, Bechtel WD, Fühn FJ and Mierau J, In vitro and in vivo studies of the non-sedating antihistamine epinastine. Arzneimittelforschung 38: 1446-1453, 1988.
172. 2-adrenoceptor agonists. Agents Actions 36: 29-32, 1992.
173. Sulakvelidze I and McDonald D, Anti-edema action of formoterol in rat trachea does not depend on capsaicin-sensitive sensory nerves. Am J Respir Crit Care Med 149: 232-238, 1994.
174. Raud J, Lundeberg T, Jansen G, Theodorsson E and Hedqvist P, Potent anti-inflammatory action of calcitonin gene-related peptide. Biochem Biophys Res Commun 180: 1429-1435, 1991.
175. Brain SD and Williams TJ, Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br J Pharmacol 86: 855-860, 1985.
176. Wallengren J and Hakanson R, Effects of substance P, neurokinin A, and calcitonin gene-related peptide in human skin and their involvement in sensory nerve-mediated responses. Eur J Pharmacol 143: 267-273, 1987.